Pulmonary function in patients with Parkinson’s disease
Objective: Analyse the pulmonary function in patients with PD. Background: Respiratory disorders are the most common causes of death in people with Parkinson's disease (PD)(1,2).…Clinical and fMRI effects of Action Observation and Motor Imagery Training on dual-task performances in Parkinson’s disease patients with postural instability and gait disorders
Objective: To assess brain functional reorganization and gait changes performing dual-task after 6 weeks of action observation training (AOT) and motor imagery (MI) associated with…Botulinum toxin treatment of muscle spasms in a case of Satoyoshi syndrome
Objective: To describe improvement in muscle spasms of the jaw and upper limb associated with Satoyoshi syndrome using botulinum toxin injections. Background: Satoyoshi syndrome is…Plasma membrane Ca2+ Atpase 1 as a candidate to mediate the degeneration of dopaminergic neurons by inflammation in Parkinson’s disease
Objective: To identify genes involved in the degeneration of the dopaminergic neurons (DN) of the substantia nigra (SN) by inflammation. Background: Parkinson’s disease (PD) is…Study on the effect of levodopa administration on serum zinc levels in Parkinson’s disease patients
Objective: Since zinc-chelating action of levodopa has been reported in the past, we measured serum zinc level in patients with Parkinson's disease (PD) at our…STAT-ON: a Wearable Inertial System to Objectively Evaluate Motor Symptoms in Parkinson’s Disease
Objective: We present a wearable inertial system for the evaluation of motor symptoms in Parkinson's Disease. Background: PD is the second neurodegenerative disease affecting to around…The carotid ultrasonography revealed vagus nerve atrophy of the patients with parkinsonism
Objective: This study aims to clarify the compare vagus nerve atrophy with Parkinson’s disease (PD) and other atypical parkinsonism. Background: Although the pathogenesis of the…Spectrum of parkinsonian phenotypes associated with GCH1 mutation.
Objective: To describe the heterogeneity of parkinsonism in patients with GCH1 mutations. Background: Dopa-responsive dystonia (DRD) is an inherited disorder that responds dramatically to levodopa…Longitudinal assessment of genetic determinants of cognitive decline in Parkinson’s disease
Objective: This study aimed to investigate the relationships between genetic variants reportedly associated with neurological disease and cognitive decline, in patients with PD over a…The Dutch Parkinson and Microbiome Study (DUPARM): Gut Microbiome Composition of Treatment-Naïve De Novo Parkinson’s Disease Patients
Objective: To establish the gut microbiome composition of de novo Parkinson’s disease (PD) patients with no history of dopaminergic medication use. Background: PD is often…
- « Previous Page
- 1
- …
- 210
- 211
- 212
- 213
- 214
- …
- 217
- Next Page »